ライフサイエンスコーパス: hospital cost

1 2 billion (28% of hospital charges or 79% of hospital cost).

2 e kidney injury, stroke, length of stay, and hospital costs).

3 plants, which comes with increased risks and hospital cost.

4 stay, development of C. difficile, or total hospital cost.

5 SQIP risk-adjustment to predict outcomes and hospital cost.

6 of Clostridium difficile colitis, and total hospital cost.

7 rally inserted central catheters (PICC), and hospital cost.

8 Excessively prolonged hospitalization and hospital cost.

9 Hospital charges were used as a proxy for hospital cost.

10 ns have been shown to significantly increase hospital cost.

11 ct of DCI on outcomes and inflation-adjusted hospital cost.

12 ty, complications, length of stay, and total hospital cost.

13 ated with increased hospital utilization and hospital costs.

14 hospital costs were strongly associated with hospital costs.

15 spitalization, length of stay in an ICU, and hospital costs.

16 dary outcomes included Medicare spending and hospital costs.

17 rate and is also associated with significant hospital costs.

18 for approximately 25% of non-implant-related hospital costs.

19 U length of stay, discharge disposition, and hospital costs.

20 stay, ICU days, nonbeneficial treatments, or hospital costs.

21 nce of pulmonary complications and increased hospital costs.

22 rtality, prolonged length of stay, and total hospital costs.

23 seem to improve outcomes without increasing hospital costs.

24 alizations and approximately $242 million in hospital costs.

25 ts had longer hospitalizations and increased hospital costs.

26 associated with decreased length of stay and hospital costs.

27 Length of stay and hospital costs.

28 sts were $27 billion representing 12% of all hospital costs.

29 associated with increased patient charges or hospital costs.

30 vascular complications, length of stay, and hospital costs.

31 ements, length of ICU and hospital stay, and hospital costs.

32 aureus prolongs length of stay and increases hospital costs.

33 length of critical care or hospital stay or hospital costs.

34 rct size, hospital length of stay, and total hospital costs.

35 tay, increased early and late mortality, and hospital costs.

36 ICU and hospital lengths of stay, and total hospital costs.

37 p VAP incur > or = USD $10,019 in additional hospital costs.

38 imaging, and total imaging relative to total hospital costs.

39 se in LOS, and nearly 7500 dollars in excess hospital costs.

40 significantly higher intensive care unit and hospital costs.

41 ital and its effects on patient outcomes and hospital costs.

42 ociated with meaningful increases in LOS and hospital costs.

43 Our primary outcome was 90-day total hospital costs.

44 ted with a 7.4% (7.1-7.6) increase in annual hospital costs.

45 , is associated with increased mortality and hospital costs.

46 cian costs were estimated as a percentage of hospital costs.

47 macy stewardship personnel time on the total hospital costs.

48 terventions, allowing possible reductions of hospital costs.

49 ed morbidity, mortality, length of stay, and hospital costs.

50 lity of life-adjusted survival and increased hospital costs.

51 37.24; P < .001) were associated with higher hospital costs.

52 .31 +/- 9.43 for OA; P < 0.001), and reduced hospital costs (12,125 +/- 14,430 for LA vs 17,594 +/- 2

53 4.1-5.5; p < .0001), and higher attributable hospital costs ($12,617; 95% confidence Interval, $10,75

54 < 0.001 and 28.0 vs 24.1 d; p < 0.001), and hospital costs ($150,569 vs $102,823; p < 0.001) were si

55 spital stay (2.06 +/- 1.06 days), and higher hospital costs [$18,579 (15,204-21,954) vs $14,063 (12,4

56 I, -0.46 to -0.16; P < 0.01) length-of-stay, hospital costs (-$2,559; 95% CI, -$4,508 to -$609; P = 0

57 outcomes from a recent randomized trial and hospital costs (2013 US$) from a university pancreatic d

58 stays (23.2 vs. 9.1 days, p < 0.001), higher hospital costs (21,144 dollars vs. 5,785 dollars, p < 0.

59 g was the fastest growing component of total hospital costs (213% increase from 1999 to 2007).

60 person/5 yr), and had 51% higher mean 5-year hospital costs ($25,608 vs. $16,913/patient).

61 +/- 17.2 vs. 16.7 +/- 15.3 h, P = 0.36), and hospital costs ($4,242 +/- $3,871 vs. $4,364 +/- 1781, P

62 cal care medicine costs represented 13.4% of hospital costs, 4.1% of national health expenditures, an

63 In 2000, CCM costs represented 13.3% of hospital costs, 4.2% of national health expenditures, an

64 (2) high turnover hospitalization, (3) total hospital cost, (4) transfer to the intensive care unit,

65 Median length of stay (17 vs. 6 days) and hospital costs ($40,903 vs. $13,434) also were higher wi

66 74 per patient, p < 0.001) and UHC estimated hospital costs ($4699 per case).

67 ant increases in both LOS (1 to 10 days) and hospital cost (5,000 dollars to 20,000 dollars).

68 ength of stay (13 [8-20] vs 4 d [1-8 d]) and hospital costs ($55,014 [$35,051-$88,007] vs $20,120 [$1

69 er and had significantly lower adjusted mean hospital costs ($6194; 95% confidence interval [CI], $57

70 rate (64 [50%] vs. 237 [34%]; p <.001), and hospital costs (70,568 dollars vs. 21,620 dollars, p <.0

71 in comparable but not significantly reduced hospital costs (7825 +/- 6,009 for LA vs 7841 +/- 13,147

72 +/- 0.6 vs. 13.9 +/- 0.3), had higher median hospital costs ($80,500 vs. $29,604, p < .0001) and medi

73 +/- 80 minutes; P < 0.0001) and higher total hospital costs ($8076 vs. $7678; P = 0.0002).

74 21 [51%] vs. 301 [28%], p = .001), and total hospital costs (83,544 dollars vs. 23,803 dollars, p < .

75 sulted in a 1.5-fold mean increase in direct hospital cost [95% confidence interval (CI) 1.49-1.58].

76 day 4 was associated with a 43% increase in hospital costs, a 29% increase in physician service cost

77 iated pneumonia is associated with increased hospital costs, a greater number of days in the intensiv

78 Hospital cost accounting data and pre-existing cost data

79 Hospital costs were obtained from the hospital cost accounting database.

80 Hospital costs were defined by using the hospital cost accounting database.

81 ed utilizing patient data generated from the hospital cost accounting system and included additional

82 , between 1996 and 2002 were downloaded from hospital cost-accounting system; sample was restricted t

83 Older age was associated with lower total hospital costs after controlling for sex, intensive care

84 Costs to taxpayers were nearly $500000 in hospital costs alone.

85 Hospital costs also declined over this period (p for tre

86 e estimated pound4.5 billion of total annual hospital costs among all women aged 55-79 years in Engla

87 Significant variability was noted in hospital costs among patients undergoing pancreatic and

88 alyses were employed to compare outcomes and hospital costs among patients who had alvimopan versus n

89 hospital discharge, and resource use (total hospital cost and discharge disposition among survivors)

90 were used to explore the association between hospital cost and in-hospital mortality, controlling for

91 n, multivariate linear regression models for hospital cost and length of stay were created to account

92 nger ICU and hospital LOS, with higher crude hospital cost and mortality rate compared with uninfecte

93 om 2001 through 2009 was performed using the Hospital Cost and Utilization Project State Inpatient Da

94 Data are from the Hospital Cost and Utilization Project State Inpatient Da

95 Methods We used the Hospital Cost and Utilization Project State Inpatient Da

96 2 (3%) per blood culture in terms of overall hospital costs and $28 (5.4%) in direct-only costs.

97 accounted for $12 475 per patient in initial hospital costs and 2.4 days of hospitalization.

98 Participants were followed up and annual hospital costs and admission rates were estimated for Ap

99 ied differences in risk-adjusted incremental hospital costs and complications probabilities were comp

100 ing of the effects of excess weight on total hospital costs and costs for different health conditions

101 Median total hospital costs and daily costs were $ 56,056 and $2,655

102 d culture contamination results in increased hospital costs and exposure to antimicrobials.

103 Primary outcomes were total hospital costs and hospital length of stay.

104 effect of periprocedural complications on in-hospital costs and length of stay of TAVR.

105 ive patient care and subsequently decreasing hospital costs and length of stay.

106 R-KP infection was associated with increased hospital costs and longer hospitalization.

107 pital mortality, ICU admission rates, and in-hospital costs and longer lengths of stay.

108 dels to investigate the associations between hospital costs and methods of self-harm.

109 Hospital costs and mortality are strongly associated wit

110 m $56.6 to $81.7 billion), the proportion of hospital costs and national health expenditures allocate

111 k-adjusted, diagnosis-related group-specific hospital costs and payments for each patient.

112 by using rates of Medicare reimbursement for hospital costs and physician fees.

113 Hospital costs and revenue at discharge were obtained fr

114 are might be an effective strategy to reduce hospital costs and the volume of patients in the ED.

115 e calculated as the difference between total hospital costs and total payments received.

116 intenance of equipment, and direct technical hospital costs) and benefit of care (based on difference

117 ntilation), resource use (length of stay and hospital costs), and outcome (mortality).

118 30-day readmission, hospital length of stay, hospital cost, and discharge disposition.

119 ciated with longer hospital stays, increased hospital costs, and 1-year mortality.

120 hospital within 90 days, hospital bed-days, hospital costs, and 6-month new disability (progression

121 drug therapies have a significant impact on hospital costs, and effective clinical informatics servi

122 The development of POAF, total hospital costs, and heart rate variability was compared

123 ry outcomes were trends in hospitalizations, hospital costs, and inpatient mortality.

124 Based on present value of future earnings, hospital costs, and lost income estimates due to illness

125 y of illness, comorbidities, length of stay, hospital costs, and mortality.

126 acteristics (mean age 58 years, 63% female), hospital costs, and perioperative mortality from the Nat

127 ios were most sensitive to variation in age, hospital costs, and probability of readmission, although

128 gth of stay, duration of antibiotic therapy, hospital costs, and surgical outcome.

129 ntilation, ICU and hospital lengths of stay, hospital costs, and the percentage of patients requiring

130 nosis before initiating therapy, to decrease hospital costs, and to prevent inappropriate antimicrobi

131 of the EXPRESS intervention on admissions to hospital, costs, and disability.

132 U.S. population, total short-term acute care hospital costs approach $11 billion dollars per year for

133 genital cardiac surgery, mortality rates and hospital costs are significantly lower than when perform

134 axis over a wide range of valganciclovir and hospital costs, as well as variation in the incidence of

135 s and regulatory agencies should risk-adjust hospital cost assessments using clinical information tha

136 The difference in mean hospital costs associated with all variables was analyze

137 y due to increased incidence of bleeding and hospital costs associated with bleeding.

138 st catheterization failed, and the inpatient hospital costs associated with complications from the pr

139 Decreased length of stay and hospital costs associated with hospitalist care are offs

140 Actual direct hospital costs associated with operating room time ($131

141 have taken place in the context of declining hospital costs associated with short-term MCS.

142 a reduction in mortality, length of stay, or hospital cost attributable to the introduction of the eI

143 uctions in resource use, usually measured as hospital costs (average decrease, 13.4%) or average leng

144 Total hospital costs averaged $15,643 (median, $13,809), $6,51

145 was constructed to determine short-term "in-hospital" costs, based on outcome data derived from a pr

146 To compare actual 90-day hospital costs between elective open and laparoscopic co

147 procedural costs by 1148 dollars and initial hospital costs by 1384 dollars (both P<0.001).

148 th no CAD are discharged, could reduce total hospital costs by 23% (P<0.001).

149 ed mean length of stay by 0.4 days and other hospital costs by nearly $1,000 ($6,846 vs. $7,811, p =

150 Hospital costs combined Medicare and private insurance r

151 h higher unadjusted total mortality rate and hospital cost compared with uninfected patients.

152 ty (RR 0.71; 95% CI, 0.58-0.87), but similar hospital costs (CR 1.05; 95% CI, 0.95-1.16) compared to

153 idence (34.8% vs. 35.2%, p = 0.950) or total hospital costs (data as medians with 25%, 75% percentile

154 p personnel time to interventions, the total hospital costs decreased by $2,439 per bloodstream infec

155 Length of stay (LOS) and total hospital costs, derived using whole-hospital cost to cha

156 Median hospital cost differed 4-fold for patients with uncompli

157 ed to estimate the mean relative increase in hospital cost due to each complication, adjusting for pa

158 ospital cost (incremental increase in median hospital cost estimated at $11,075; 95% confidence inter

159 (5.4 days vs 10.0 days; P < 0.001) and total hospital costs (euro2919 vs euro4262; P < 0.001) were si

160 mechanical ventilation, length of stay, and hospital costs, even at a time when patients are sicker.

161 EGDT reduced length of stay such that net hospital costs fell approximately 22.9% ($8,413-$8,978).

162 complications are associated with increased hospital costs following major surgery, but the mechanis

163 ociation of postoperative complications with hospital costs following total gastrectomy for gastric a

164 Data on hospital costs for 17 139 patients admitted to Massachus

165 care costs based on inpatient and outpatient hospital costs for 28 DCD and 198 donation after brain d

166 The total hospital costs for all patients with severe sepsis incre

167 the perspective of the hospital and included hospital costs for each admission plus the total annual

168 ess body weight is associated with increased hospital costs for middle-aged and older women in Englan

169 se job satisfaction, job turnover rates, and hospital costs for temporary agency nurses will improve

170 nificant differences in Medicare spending or hospital costs for the hospitalization.

171 illion, representing a 6% reduction in total hospital costs for these patients.

172 Hospital costs from enrollment to discharge were high an

173 The primary endpoint was total direct hospital costs from the start of treatment.

174 Primary endpoint: total direct hospital costs from the start of treatment.

175 Its relation to hospital costs has not been validated to date.

176 Median length of stay was shorter and hospital costs higher with endovascular versus surgical

177 Pharmaceutical costs were lowest and hospital costs highest among underserved groups, includi

178 d] vs community acquired [3 d]), and median hospital costs (hospital acquired [$38,369] vs healthcar

179 inpatient bleeding, and decreased overall in-hospital cost in STEMI patients undergoing PPCI.

180 after CABG but does not reduce POAF or total hospital costs in any appreciable way.

181 s not associated with significant changes in hospital costs in patients hospitalized with sepsis in N

182 tion on the rate of readmission or death and hospital costs in patients with heart failure (HF).

183 d patient satisfaction with care and reduces hospital costs in seriously ill patients.

184 his difference was also manifested in higher hospital costs in the UOR group (p = 0.0235).

185 lity (2.7% vs. 2.1%; p < 0.001), and overall hospital costs (in $1000; 37 [27-64] vs. 28 [21-48]; p <

186 Adjusted mean hospital cost increased from $8974 (days 0-1) to $17,745

187 Although total hospital costs increased over time, the rate of increase

188 on was independently predictive of increased hospital cost (incremental increase in median hospital c

189 Adjusted total hospital costs incurred by obese patients were 3.7% high

190 with increased intensive care unit stay and hospital cost, independent of trauma severity.

191 Total short-term acute care hospital costs (index and readmissions) in the first yea

192 boratory, but the impact on patient care and hospital costs is a matter of speculation.

193 Of the 2 major components of hospital costs, length of stay was significantly increas

194 Hospital cost, LOS, and readmissions are strongly associ

195 .3 versus 4.5 days; P<0.0001), with lower in-hospital cost (mean $18,640 versus $19,967 [median $14,4

196 yses were performed on key inputs including: hospital costs, mortality benefit, hazard ratio for hosp

197 ted therapy was associated with an increased hospital cost of $7,028 and an increase in both discount

198 nited States in 2003 at an annual aggregated hospital cost of > $16 billion, or nearly two thirds of

199 py in the Netherlands showed that mean total hospital cost of extracorporeal life support treatment i

200 he United States with 8,500 deaths and total hospital costs of $4.4 billion.

201 The mean hospital costs of a singleton, twin, and HOM child to ag

202 However, few estimates have been made of the hospital costs of assessing and treating self-harm.

203 is large and detailed economic evaluation of hospital costs of extracorporeal life support therapy in

204 -adjusted incidence, outcome, and associated hospital costs of severe sepsis in United States childre

205 ad equivalent graft survival, but triple the hospital costs of unaffected recipients.

206 examining the effect of hospitalist care on hospital costs or on medical utilization and costs after

207 ed with prolonged hospitalization, increased hospital costs, patient dissatisfaction, morbidity, and

208 The total hospital cost per bloodstream infection was lower in the

209 The overall mean hospital cost per episode of self-harm was pound809.

210 nd hospital lengths of stay (LOS), and total hospital cost per patient.

211 5+/-7 versus 3+/-2 days; P=0.0097) and total hospital costs per admission ($26,826+/-29,497 versus $1

212 pre-BIG group, 6.1 [4.8] days; P = .03), and hospital costs per patient ($4772 per patient; P = .03)

213 In-hospital costs per patient (+30.5%, +5,443 Euro per pati

214 Mean total hospital costs per patient (hospital accounting system)

215 Hospital costs per patient were $39,508 (interquartile r

216 length of stay, 30-day readmission rate, and hospital costs per patient.

217 Total 90-day hospital costs ranged from &OV0556;10474 to &OV0556;2086

218 pic subgroups had significantly higher total hospital costs, ranging from &OV0556;501 (<75 years ASA

219 upon operating room exit is associated with hospital cost reductions.

220 Hospital costs related to the transplant were 29.5% lowe

221 ality risk, longer hospital stay, and higher hospital costs relative to bacterial bloodstream infecti

222 trospective analysis was performed using the Hospital Cost Report Information System (Centers for Med

223 spital Association dataset, and (d) Medicare Hospital Cost Report Public Use files and wage index fil

224 erved as the primary end point whereas total hospital costs represented a secondary end point.

225 Overall hospital costs represented the primary end point, wherea

226 Hospital costs, revenues, and contribution margin (defin

227 ength of stay by 1.6 days (P = 0.002), and a hospital cost savings of $1492 per patient (P = 0.01).

228 ial benefits of pulse oximeters and possible hospital cost-savings by targeting oxygen therapy might

229 complexity are more effective predictors of hospital costs than complications.

230 urgical complexity predict more variation in hospital costs than complications.

231 her 30-day mortality, Medicare spending, and hospital costs than patients admitted to a general hospi

232 se who were adherent had significantly lower hospital costs than the other groups; pharmacy costs wer

233 h surgical complexity, is more predictive of hospital costs than the subsequent treatment of postoper

234 e predictors of inpatient morality and total hospital costs (THC).

235 We compared hospital costs, third-party reimbursement (ie, payer cos

236 e over 2 years, and medical resource use and hospital costs through 12 months were used to project li

237 nd total hospital costs, derived using whole-hospital cost to charge ratios, were calculated for each

238 care reimbursement levels using the ratio of hospital costs to Medicare reimbursement and categorized

239 r using US EQ-5D scores) and accrued greater hospital costs (UK pound101 [SE pound37]; US $145 [SE $5

240 (6 days vs 9 days, P = 0.016), and lower in-hospital costs (US $16,717 vs US $24,014) were significa

241 ated the independent association of age with hospital costs using linear regression.

242 Adjusted hospital costs varied over 60% between the highest and l

243 7-2.96], P = < 0.0001) and higher cumulative hospital cost (VH: RR 1.97[95% CI 1.64-2.37], P < 0.0001

244 hip/knee replacements was $26.0 billion, the hospital cost was $9.1 billion, and the amount of reimbu

245 Total hospital cost was highest in the West, whereas discharge

246 The mean total hospital cost was significantly higher for endovascular

247 Total ICU and hospital cost were also reduced by 24.2% (95% CI, -41.4%

248 Length of stay and total hospital cost were comparable between the 2 groups (P >

249 ects of any and each complication on LOS and hospital cost were estimated in multivariable models, ad

250 leeding, transfusion, length of stay, and in-hospital cost were secondary outcomes.

251 underwent splenectomy, 6.1% died, and median hospital costs were $14,317.

252 For all studied procedures, mean hospital costs were $19626 (119%) higher for patients wi

253 Overall hospital costs were $4.4 billion (6.3% of the expenditur

254 Median 1-year total unadjusted hospital costs were $46,302 per patient.

255 ntly 21.7 days shorter (P = 0.0484) and mean hospital costs were $60,729 lower (P = 0.02) than in the

256 In 2002, hospital costs were 155% those of 1996 levels; inpatient

257 Total hospital costs were also higher in those who developed d

258 Hospital costs were analyzed using cost-to-charge ratios

259 , compression, or vesicoureteral reflux, and hospital costs were analyzed.

260 Hospital costs were assessed using price-standardized Me

261 Hospital costs were assessed using price-standardized Me

262 tions to total EGS frequency, mortality, and hospital costs were assessed.

263 Estimates of hospital costs were based on a subset of the patients tr

264 Average length of stay and total hospital costs were calculated and compared.

265 All hospital costs were calculated based on charges after co

266 Inflation-adjusted inpatient hospital costs were calculated for first year of life us

267 , quality of life, medical resource use, and hospital costs were collected during the trial and used

268 admission rate, length of hospital stay, and hospital costs were collected from the University Health

269 findings, length of hospital stay, and total hospital costs were compared.

270 Hospital costs were defined by using the hospital cost a

271 Hospital costs were estimated using Medicare reimburseme

272 The mean total hospital costs were euro 106.263 (euro 83.841 to euro 12

273 hospital stay, mortality rates, and ICU and hospital costs were extracted.

274 Discharge delays and median total direct hospital costs were higher for patients with OPAT delays

275 Discharge delays and median total direct hospital costs were higher in patients with OPAT delays:

276 Initial hospital costs were increased by 2881 dollars per patien

277 neurysms, discharge outcomes were better and hospital costs were lower after endovascular treatment t

278 an difference pound 19, 95% CI 11-27); total hospital costs were lower for those infants, but the dif

279 Total hospital costs were lower in ELC (9349&OV0556; vs 12,361

280 Daily and total hospital costs were lower in older patients.

281 Hospital costs were lower in the intervention group ($11

282 Annual hospital costs were lowest for women with a BMI of 20.0

283 Ninety-day hospital costs were measured uniformly in all hospitals

284 Hospital costs were modeled using multivariable linear r

285 Hospital costs were obtained from the hospital cost acco

286 The in-hospital costs were offset significantly at the 6-month

287 As a result, overall initial hospital costs were only $582 per patient higher with di

288 Associations of BMI with hospital costs were projected to the 2013 population of

289 All in-hospital costs were recorded.

290 Hospital costs were significantly less in older patients

291 Between 17.4% and 39.0% of total hospital costs were spent on critical care, and a total

292 ive complications, length of stay, and total hospital costs were strongly associated with hospital co

293 urgical complexity, and outcomes, along with hospital costs, were analyzed for a random sample of 587

294 d to determine the impact of care setting on hospital costs while controlling for patient demographic

295 ificant increase in reoperation rates and in-hospital costs with laparoscopic colectomy.

296 avings (microbiology, pharmacy, and indirect hospital costs) with the routine use of an ISDD from a h

297 were independently associated with increased hospital costs, with major bleeding, arrhythmia, and dea

298 Ethics consultations also reduce hospital costs without diminishing the quality of care.

299 ction, increase bed availability, and reduce hospital costs without increasing adverse patient outcom

300 ting data on the influence of laparoscopy on hospital costs, without separate analyses based on opera